• Fairness and Justice? Post-9/11 Muslim Charity Prosecution

    By Katherine Hughes, Truthout | Op-Ed

    2014 920 justice st(Image: EL / TO; Adapted: JMT Images, Rana Ossama)My passion for the protection of civil liberties was sparked at the age of 14 when I saw a documentary on the Allies' liberation of Bergen-Belsen. For the past 40 years, in an effort to understand how something like that could happen, I've been reading first-hand accounts of 1930s and 1940s Europe and the former Soviet Union. Over the last 25 years I began noticing similar circumstances in both Europe and the United States: wars creating millions of refugees, financial crises, erosions of workers' rights and sharpening income inequality, along with national and individual poverty and debt, a xenophobic and racist climate, and attacks on civil liberties, including freedom of speech. My alarm grew as I witnessed the post-9/11 demonization of Muslims. I have always known that if anything like this happened in my lifetime, not only did I not want any part of it; I did not want to be a bystander. It was for this reason that I decided to attend the trial of Rafil Dhafir.



  • Corruption, Clientelism and Censorship in Greece's Media Landscape

    Corruption, Clientelism and Censorship in Greece's Media Landscape

    By Michael Nevradakis, Truthout | News Analysis

    It was just over one year ago when Greece was, once again, thrust into the international limelight. On June 11, 2013, the Greek government, in a sudden and surprise move, immediately shut down ERT, the country's national public broadcaster. That evening, ERT's frequencies throughout Greece went dark, putting an end to a national broadcasting institution that had been on the air continuously since 1938.

  • A New Way Insurers Are Shifting Costs to the Sick

    A New Way Insurers Are Shifting Costs to the Sick

    By Charles Ornstein, ProPublica | Report

    Health insurance companies are no longer allowed to turn away patients because of their pre-existing conditions or charge them more because of those conditions. But some health policy experts say insurers may be doing so in a more subtle way: by forcing people with a variety of illnesses - including Parkinson's disease, diabetes and epilepsy - to pay more for their drugs. Insurers have long tried to steer their members away from more expensive brand name drugs, labeling them as "non-preferred" and charging more.